Themes
Mirum expands rare disease portfolio with digestive disorder drugs
Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.
AbCellera and Regeneron expand antibody discovery collaboration
ADDF invest in BrainScope for Alzheimer’s prediction biomarker
Drug manufacturing automation key as populations age, says Lotte Biologics CEO
Market cap rebound by top 20 biopharmaceutical companies in Q2 2023
EMA CHMP recommends approval for Moderna’s updated Covid-19 vaccine
